Keeping neurons alive: The molecular control of apoptosis (part I)

Neuroscientist

Volumn 2, Issue 3, 1996, Pages 181-190

  Bredesen, Dale E ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Bcl 2; Cysteine protease; Endonuclease; Neurodegeneration; Programmed cell death; Reactive oxygen species

Indexed keywords

EID: 0000620478     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200313     Document Type: Review

References (117)

1. Glücksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 1951;26:59-86.
2. Lockshin RA, Williams CM. Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol 1964;10:643-649.
3. Tata JR. Requirement for RNA and protein synthesis for induced regression of tadpole tail in organ culture. Dev Biol 1966;13 77-94.
4. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239.
5. Hockenbery D, Nuñez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-336.
6. Clem RJ, Fechheimer M, Miller LK. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 1991; 254:1388-1390.
7. Hershberger PA, Dickson JA, Friesen PD. Site-specific mutagenests of the 35-kilodalton protein gene encoded by Autographa californica nuclear polyhedrosis virus: cell line-specific effects on virus replication. J Virol 1992;5525-5533.
8. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the program cell death hypothesis. Immunol Today 1991;12:102-105.
9. Gougeon ML, Oliver R, Garcia S, et al. Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV-infected patients. CR Acad Sci 1991;312:529-37.
10. Liu YJ, Joshua DE, Williams GT, et al. Mechanism of antigen-driven selection in germinal centres. Nature 1989;342:21-28.
11. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In: Tomei LD, FO Cope, editors. Apoptosis: the molecular basis of cell death. Plainview, NY: Cold Spring Harbor Laboratory Press 1991;5-29.
12. Lennon SV, Martin SJ, Cotter TG. Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif 1991;24:203-214.
13. Barrett G, Bartlett P. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci U S A 1994;91:6501-6505.
14. Tomei LD, Shapiro JP, Cope FO. Apoptosis in C3H/10T 1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci U S A 1992;90:853-857.
15. Mirabelli F, Salis A, Perotti M, et al. Alterations of surface morphology caused by the metabolism of menadione in mammalian cells are associated with the oxidation of critical sulfhydryl groups in cytoskeletal protein. Biochem Pharmacol 1988;37: 3423-3427.
16. Mirabelli F, Salis A, Marinoni V, et al. Menadione-induced bleb formation in hepatocytes is associated with the oxidation of thiol groups in actin. Arch Biochem Biophys 1988;264:261-269.
17. Fadok VA, Voelker DR, Campbell PA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-2216.
18. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284:555-556.
19. McConkey DJ, Orrenius S. Cellular signaling in thymocyte apoptosis. In: Tomei LD, FO Cope, editors. Apoptosis: the molecular basis of cell death. Plainview, NY: Cold Spring Harbor Laboratory Press 1991;227-246.
20. Batistatou A ,Greene LA. Aurintricarboxylic acid rescues PC 12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J Cell Biol 1991;115:461-471.
21. Gaido ML, Cidlowski JA. Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes. NUC18 is not histone H2B. J Biol Chem 1991;266:18580-18585.
22. Tomei LD. Apoptosis: a program for death or survival? In: Tomei LD, FO Cope, editors. Apoptosis: the molecular basis of cell death. Plainview, NY: Cold Spring Harbor Laboratory Press, 1991;297-316.
23. Buttyan R. Genetic response of prostate cells to androgen deprivation: insights into the cellular mechanism of apoptosis. In: Tomei LD, FO Cope, editors. Apoptosis: the molecular basis of cell death. Plainview, NY: Cold Spring Harbor Laboratory Press, 1991;157-173.
24. Duguid JR, Bohmont CW, Liu N, Tourtellotte WW. Changes in brain gene expression shared by scrapie and Alzheimer's disease. Proc Natl Acad Sci U S A 1989;86:7260-7264.
25. Abate C, Patel L, Rauscher FJ III, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990;249: 1157-1161.
26. Martin DP, Ito A, Horigome K, et al. Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J Neurobiol 1992;23:1205-1220.
27. Fesus L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 1987;224:104-108.
28. Fesus L, Thomazy V, Autuori F, et al. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett 1989;245:150-154.
29. Piacentini M, Davies PJA, Fesus L. Tissue transglutaminase in cells undergoing apoptosis. In: Tomei LD, FO Cope, editors. Apoptosis: the molecular basis of apoptosis in disease. Plainview, NY: Cold Spring Harbor Laboratory Press, 1994;143-163.
30. Owens GP, Hahn WE, Cohen JJ. Identification of mRNAs associated with programmed cell death in immature thymocytes. Molec Cell Biol 1991;11:4177-4188.
31. Estus S, Zaks WJ, Freeman RS, et al. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 1994;126(6 Pt 1):1717-1727.
32. Freeman R, Estus SEM Jr. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron 1994;12:343-55.
33. Yuan J, Shaham S, Ledoux S, et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993;75:641-652.
34. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994;76:665-676.
35. Yuan J, Horvitz HR. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev Biol 1990;138:33.
36. Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992;356:768-774.
37. Cerretti DP, Kozlosky CJ, Mosley B, et al. Molecular cloning of the interleukin-1β converting enzyme. Science 1992;256:97-100.
38. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995;82:1-20.
39. Kuida K, Lippke JA, Ku G, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995;267:2000-2003.
40. Lazebnik YA, Kaufmann SH, Desnoyers S, et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-347.
41. Kayalar C, Ord T, Testa MP, et al. Cleavage of actin by ICE to reverse DNase I inhibition. Proc Natl Acad Sci U S A 1996;93: 2234-2238.
42. Oppenheim RW. Naturally occurring cell death during neural development. Trends Neurosci 1985;17:487-493.
43. Rabizadeh S, Oh J, Zhong L, et al. Induction of apoptosis by the low-affinity NGF receptor. Science 1993;261:345-348.
44. Rabizadeh S, Bitler CM, Butcher LL, Bredesen DE. Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity. Proc Natl Acad Sci U S A 1994;91:10703-10706.
45. Johnson D, Lanahan A, Buck CR, et al. Expression and structure of the human NGF receptor. Cell 1986;47:545-554.
46. Radeke MJ, Misco TP, Hsu C, Herzenberg LA, et al. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 1987;325:593-597.
47. Smith C, Farrah T, Goodwin R. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76:959-962.
48. Wong G, McHugh T, Weber R, Goeddel D. Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proc Natl Acad Sci U S A 1991;88:4372-6.
49. Zagury J-F, et al. Is GP120 peptide identity with FAS relevant to AIDS pathogenesis? In: Apoptosis in AIDS and cancer. Paris: L.D. Tomei and L. Montagnier, 1993.
50. Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670.
51. Itoh N, Nagata S. A novel protein domain required for apoptosis. J Biol Chem 1993;268:10932-10937.
52. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74:845-853.
53. Chapman BS. A region of the 75 kDa neurotrophin receptor homologous to the death domains of TNFR-I and Fas. FEBS Lett 1995;374:216-220.
54. NTR death domain. In preparation.
55. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-512.
56. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-KB activation. Cell 1995;81:495-504.
57. Boldin MP, Varfolomeev EE, Pancer Z, et al. A novel protein that interacts with the death domain of Fas/AP01 contains a sequence motif related to the death domain. J Biol Chem 1995; 270:7795-7798.
58. Stanger BZ, Leder P, Lee T-H, et al. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995;81:479-482.
59. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993;259:1769-1771.
60. Jarvis WD, Kolesnick RN, Fornari FA, et al. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci U S A 1994;91:73-77.
61. Dobrowsky RT, Werner MH, Castellino AM, et al. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994;265:1596-1599.
62. Davies AM. Neurobiology. Tracking neurotrophin function [news comment]. Nature 1994;368:193-194.
63. Feinstein DL, Larhammer D. Identification of a conserved protein motif in a group of growth factor receptors. FEBS Lett 1990; 272:7-11.
64. Higashijima T, Burnier J, Ross EM. Regulation of Gi and Go by mastoparan, related amohiphilic peptides, and hydrophobic amines. J Biol Chem 1990;265:14176-14186.
65. Knipper M, Beck A, Rylett J, Breer H. Neurotrophin induced cAMP and IL3 responses in PC12 cells. FEBS Lett 1993;324: 147-152.
66. Rukenstein A, Rydel RE, Greene LA. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J Neurosci 1991;11:2552-2563.
67. NGFR involved in developmental neural cell death? Dev Neurosci 1994;16:207-211.
68. Hempstead BL, Martin-Zanca D, Kaplan DR, et al. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991;350:678-683.
69. Mufson EJ, Higgins GA, Kordower JH. Nerve growth factor receptor immunoreactivity in the New World monkey (Cebus apella) and human cerebellum. J Comp Neurol 1991;308:555-575.
70. Pflug BR, Onoda M, Lynch JH, Djakiew D. Reduced expression of the low-affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 1992;52: 5403-5406.
71. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 1993;74:609-619.
72. Yonish-Rouach E, Resnitzky D, Lotem J, et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991;352:345-347.
73. Lowe SW, Schmitt EM, Smith SW, et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362:847-849.
74. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
75. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992;359:554-6.
76. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359:552-554.
77. Myers KM, Fiskum G, Liu Y, et al. Bcl-2 protects neural cells from cyanide/aglycemia induced lipid oxidation, mitochondrial injury, and loss of viability. J Neurochem 1995;65:2432-2440.
78. Jacobson MD, Burne JF, King MP, et al. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993;361:365-369.
79. Hockenbery D, Oltvai ZN, Yin X, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
80. Bredesen DE. Neuronal apoptosis: genetic and biochemical modulation. Apoptosis II: The molecular basis of apoptosis in disease. Plainview, NY; Cold Spring Harbor Laboratory Press 1994: 397-421.
81. Pierce GB, Parchment RE, Lewellyn AL. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 1991;46:181-186.
82. Rabizadeh S, Gralla EB, Borchelt DR, et al. Mutations associated with amyotrophic lateral sclerosis convert Superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci U S A 1995;92:3024-3028.
83. Roy N, Mahadevan MS, McLean M, et al. The gene for neuronal apoptosis inhibiting protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995;80:167-178.
84. Crook NE, Clem RJ, Miller LK. An apoptosis-inhibiting baculovirus gene with a zince finger-like motif. J Virol 1993;67: 2168-2174.
85. Beckman JS, Chen J, Crow JP, Ye YZ. Reactions of nitric oxide, superoxide and peroxynitrite with Superoxide dismutase in neurodegeneration. Prog Brain Res 1994;103:371-380.
86. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993;24:2002-2009.
87. Forloni G, Angeretti N, Chiesa R, et al. Neurotoxicity of a prion protein fragment. Nature 1993;362:543-546.
88. Woolf NJ, Jacobs RW, Butcher LL. The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease. Neurosci Lett 1989;96:277-282.
89. Gelbard HA, James HJ, Sharer LR, et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive en cephalopathy. Neuropathol Appl Neurobiol 1995;21: 208-217.
90. Geiger KD, Gurushanthaiah D, Howes EL, et al. Cytokine-mediated survival from lethal herpes simplex virus infection: role of programmed neuronal death. Proc Natl Acad Sci U S A 1995; 92:3411-5.
91. Li Y, Sharov VG, Jiang N, et al. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am J Pathol 1995;146:1045-1051.
92. Cotman C. Apoptosis in the brains of patients with Alzheimer's disease. Satellite Symposium on Neuronal Apoptosis. Miami (FL): Society for Neuroscience, 1994.
93. Harley A, Stone JM, Heron C, et al. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's Disease. J Neurochem 1994;63:1987-1990.
94. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995;15(5 Pt 2):3775-87.
95. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
96. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig, RW. MCL1, a gene expressed in programed myeloid cell differentiation, has sequence similarity to BCL-2. Proc Natl Acad Sci U S A 1993; 90:3516-3520.
97. Marchini A, Tomkinson B, Cohen JI, Kieff E. BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensable for B-lymphocyte transformation and virus replication. J Virol 1991; 65:5991-6000.
98. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev 1994;8:1613-1626.
99. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. Ich-1, an Ice/ ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994;78:739-750.
100. Faucheau C, Diu A, Chan AWE, Blanchet A-M, et al. A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 1995;14: 1914-1922.
101. Fernandes-Alnemri T, Litwack G, Alnemri ES. Mch2, a new member of the apoptotic ced-3/Ice cysteine protease gene family. Cancer Res 1995;55:2737-2742.
102. Tewari M, Quan LT, O'Rourke K, Desnoyers S, et al. Yama/ CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801-809.
103. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptosis protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994;269:30761-30764.
104. Shi L, Kam CM, Powers JC, Aebersold R, Greenberg A. Purification of three cytotoxic lympocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 1992;176:1521-1529.
105. Sarin A, Adams DH, Henkart PA. Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J Exp Med 1993;178:1693-1700.
106. Wong GHW, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase Is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989;58:923-931.
107. Crowe PD, VanArsdale TL, Walter BN, Ware CF, et al. A novel lymphotoxin-b-specific receptor. Science 1994;264:707-710.
108. Trauth BC, Klas C, Peters AM, Matzku S, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-305.
109. White K, Grether ME, Abrams JM, et al. Genetic control of programmed cell death in Drosophila. Science 1994;264:677-683.
110. Sato T, Irie S, Kitada S, Reed JC. FAP-1: a protein tyrosine phosphatase that associated with Fas. Science 1995;268:411-415.
111. Gagliardini V, Fernandez P-A, Lee RKK, et al. Prevention of vertebrate neuronal death by the crmA gene. Science 1994;263: 826-828.
112. White E, Sabbatini P, Debbas M, Wold WSM, et al. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol Cell Biol 1992;12:2570.
113. Wang H-G, Millan JA, Cox AD, Der CJ, et al. R-Ras promotes apoptosis casued by growth factor deprivation via a bcl-2 suppressible mechanism. J Cell Biol 1995;129:1103-1114.
114. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, et al. Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-518.
115. Wong GHW, Kamb A, Tartaglia LA, Goeddel DV. Possible protective mechanisms of tumor necrosis factors against oxidative stress. In: Scandalios JG, editor. Current communications in cell and molecular biology: molecular biology of free radical scavenging systems. Vol. 5. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1992;69.
116. Mangeney M, Lingwood CA, Taga S, Caillou B, et al. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res 1993;53:5314-5319.
117. Haimovitz-Friedman A, Kan C-C, Ehleiter D, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994;180:525-535.